Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland · Delayed Price · Currency is CHF
14.80
-0.70 (-4.52%)
Apr 2, 2026, 9:26 AM CET
Revenue by Segment
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Research and Development of Pharmaceutical Drugs | 19.13M | 51.39M | 9.06M | 6.09M | 5.76M | | | | | |
Research and Development of Pharmaceutical Drugs Growth | -62.78% | 467.41% | 48.62% | 5.76% | 9.59% | | | | | |
| 19.13M | 51.39M | 9.06M | 6.09M | 5.76M | | | | | |
| -62.78% | 467.41% | 48.62% | 5.76% | 9.59% | | | | | |
Source: S&P Global Market Intelligence.
